Found: 1752
Select item for more details and to access through your institution.
Zebrafish Models in Toxicology and Disease Studies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8608, doi. 10.3390/ijms25168608
- By:
- Publication type:
- Article
Examining the results of cardiovascular outcome trials.
- Published in:
- Practice Nursing, 2019, v. 30, n. 2, p. 87, doi. 10.12968/pnur.2019.30.2.87
- By:
- Publication type:
- Article
New pharmacological approaches to diabetes management.
- Published in:
- Practice Nursing, 2015, v. 26, n. 3, p. 140, doi. 10.12968/pnur.2015.26.3.140
- By:
- Publication type:
- Article
51. Jahrestagung der Österreichischen Diabetes Gesellschaft.
- Published in:
- 2023
- Publication type:
- Abstract
Retraction Note: The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series.
- Published in:
- Integrative Cancer Therapies, 2021, v. 20, p. 1, doi. 10.1177/15347354211032283
- By:
- Publication type:
- Article
Palladium-Catalyzed Arylation of Carbasugars Enables the Discovery of Potent and Selective SGLT2 Inhibitors.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 44, p. 14022, doi. 10.1002/ange.201608758
- By:
- Publication type:
- Article
Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 6, p. 755, doi. 10.1007/s00592-024-02252-x
- By:
- Publication type:
- Article
Assessing early tubular protective effects of SGLT2 inhibitor empagliflozin against type 2 diabetes mellitus using functional magnetic resonance imaging.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 4, p. 473, doi. 10.1007/s00592-023-02220-x
- By:
- Publication type:
- Article
Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 12, p. 1651, doi. 10.1007/s00592-023-02154-4
- By:
- Publication type:
- Article
Diabetic patients with and without sodium-glucose cotransporter-2 inhibitors use and cataract risk: real-world observational investigation.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 7, p. 981, doi. 10.1007/s00592-023-02087-y
- By:
- Publication type:
- Article
Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 7, p. 917, doi. 10.1007/s00592-023-02063-6
- By:
- Publication type:
- Article
Effect of sodium–glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 2, p. 191, doi. 10.1007/s00592-022-01981-1
- By:
- Publication type:
- Article
Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 4, p. 519, doi. 10.1007/s00592-021-01830-7
- By:
- Publication type:
- Article
Risk of lower extremity amputations in patients with type 2 diabetes using sodium-glucose co-transporter 2 inhibitors.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 2, p. 233, doi. 10.1007/s00592-021-01805-8
- By:
- Publication type:
- Article
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 8, p. 1059, doi. 10.1007/s00592-021-01681-2
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 7, p. 869, doi. 10.1007/s00592-021-01686-x
- By:
- Publication type:
- Article
Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 1, p. 5, doi. 10.1007/s00592-020-01542-4
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 10, p. 1181, doi. 10.1007/s00592-020-01533-5
- By:
- Publication type:
- Article
The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 10, p. 1129, doi. 10.1007/s00592-020-01529-1
- By:
- Publication type:
- Article
Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Trend 2010–2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 3, p. 367, doi. 10.1007/s00592-019-01445-z
- By:
- Publication type:
- Article
The roots of SGLT inhibition: Laurent-Guillaume de Koninck, Jean Servais Stas and Freiherr Josef von Mering.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 1, p. 29, doi. 10.1007/s00592-018-1206-z
- By:
- Publication type:
- Article
SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 503, doi. 10.1007/s00592-018-1116-0
- By:
- Publication type:
- Article
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2017, v. 54, n. 1, p. 19, doi. 10.1007/s00592-016-0892-7
- By:
- Publication type:
- Article
Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.
- Published in:
- Acta Diabetologica, 2016, v. 53, n. 6, p. 863, doi. 10.1007/s00592-016-0856-y
- By:
- Publication type:
- Article
Effect of SGLT2 Inhibitors on Risk of Stroke in Diabetes: A Meta-Analysis.
- Published in:
- Cerebrovascular Diseases, 2022, v. 51, n. 5, p. 585, doi. 10.1159/000521782
- By:
- Publication type:
- Article
Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors.
- Published in:
- BMC Molecular & Cell Biology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12860-020-00279-w
- By:
- Publication type:
- Article
Glucoregulatory Properties of Fermented Soybean Products.
- Published in:
- Fermentation (Basel), 2023, v. 9, n. 3, p. 254, doi. 10.3390/fermentation9030254
- By:
- Publication type:
- Article
Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model.
- Published in:
- Yonago Acta Medica, 2019, v. 62, n. 1, p. 30, doi. 10.33160/yam.2019.03.005
- By:
- Publication type:
- Article
The New Diagnosis-Related Group Reimbursement System and Laboratory Test Quality in Korea: Analysis of External Quality Assessment Results.
- Published in:
- Healthcare (2227-9032), 2020, v. 8, n. 2, p. 127, doi. 10.3390/healthcare8020127
- By:
- Publication type:
- Article
Qualitative and Quantitative Determination of Dapagliflozin Propanediol Monohydrate and Its Related Substances and Degradation Products Using LCMS and Preparative Chromatography Methods.
- Published in:
- Baghdad Science Journal, 2023, v. 20, p. 1901, doi. 10.21123/bsj.2023.7596
- By:
- Publication type:
- Article
Discovery of UDP-Glycosyltransferases and BAHD-Acyltransferases Involved in the Biosynthesis of the Antidiabetic Plant Metabolite Montbretin A.
- Published in:
- Plant Cell, 2018, v. 30, n. 8, p. 1864, doi. 10.1105/tpc.18.00406
- By:
- Publication type:
- Article
Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 1, p. 35, doi. 10.1007/s40256-021-00486-6
- By:
- Publication type:
- Article
Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 1, p. 69, doi. 10.1007/s40256-021-00484-8
- By:
- Publication type:
- Article
SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 6, p. 701, doi. 10.1007/s40256-021-00503-8
- By:
- Publication type:
- Article
Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 2, p. 123, doi. 10.1007/s40256-020-00423-z
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 419, doi. 10.1007/s40256-020-00397-y
- By:
- Publication type:
- Article
Cardiovascular Protection with Anti-hyperglycemic Agents.
- Published in:
- American Journal of Cardiovascular Drugs, 2019, v. 19, n. 3, p. 249, doi. 10.1007/s40256-019-00325-9
- By:
- Publication type:
- Article
Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.
- Published in:
- Pharmacology Research & Perspectives, 2017, v. 5, n. 1, p. n/a, doi. 10.1002/prp2.292
- By:
- Publication type:
- Article
THE ROLE OF SODIUM‐POTASSIUM‐CHLORIDE COTRANSPORTER IN LPS‐INDUCED ALVEOLAR MACROPHAGE ACTIVATION.
- Published in:
- Respirology, 2018, v. 23, p. 229, doi. 10.1111/resp.13420_387
- Publication type:
- Article
Sodium/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains.
- Published in:
- Neuropathology, 2020, v. 40, n. 5, p. 482, doi. 10.1111/neup.12665
- By:
- Publication type:
- Article
Use of Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors Beyond Diabetes: On the Verge of a Paradigm Shift?
- Published in:
- Rhythmos, 2020, v. 15, n. 1, p. 1
- By:
- Publication type:
- Article
Cardiology News/Recent Literature Review/Second Quarter 2018.
- Published in:
- Rhythmos, 2018, v. 13, n. 3, p. 62
- By:
- Publication type:
- Article
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 5, p. 450, doi. 10.3390/cells13050450
- By:
- Publication type:
- Article
Canagliflozin, an Inhibitor of the Na + -Coupled D-Glucose Cotransporter, SGLT2, Inhibits Astrocyte Swelling and Brain Swelling in Cerebral Ischemia.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 18, p. 2221, doi. 10.3390/cells12182221
- By:
- Publication type:
- Article
Intracellular Angiotensin II Stimulation of Sodium Transporter Expression in Proximal Tubule Cells via AT 1 (AT 1a) Receptor-Mediated, MAP Kinases ERK1/2- and NF-кB-Dependent Signaling Pathways.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 11, p. 1492, doi. 10.3390/cells12111492
- By:
- Publication type:
- Article
Anti-Inflammatory Properties of the SGLT2 Inhibitor Empagliflozin in Activated Primary Microglia.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3107, doi. 10.3390/cells11193107
- By:
- Publication type:
- Article